CPT1A and acute myeloid leukemia: Furthermore, high expression levels of carnitine palmitoyl transferase 1A (CPT1A) and the carnitine transporter CT2 (SLC22A16) also contribute to promoting FAO and constitute therapeutic targets for AML subsets [23,24,25].